It is now known that the imbalance of tirzepatide for GIPR >> GLP1R, as well as the mid-position of the fatty diacid moiety, probably lend the molecule to superior effects on glycemia (and obesity, which is covered elsewhere) [64, 114]. This evidence concerns the gene GIPR and obesity disorder.